Melanoma Trial, Recruiting (NCT05253872)

Melanoma Trial, Recruiting NCT05253872 Sponsor: Herlev and Gentofte Hospital Condition: Melanoma

Printed from Voxsanity (voxsanity.com.au) — NCT05253872 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Melanoma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are able to read and understand Danish
You are willing and able to sign a consent form agreeing to take part
You have had surgery to treat an early-stage melanoma (stage IA to IIA) within the last 3 months

Who may not be able to join:

You have been diagnosed with a more advanced melanoma (stage IIB, IIC, III, or IV)
You are considered at high risk of developing a new melanoma — for example, because you have a condition called dysplastic nevus syndrome, or because melanoma runs in your family
You have had melanoma before the current diagnosis
You have had any other type of cancer in the past, not counting certain common skin cancers (non-melanoma skin cancers)
You have a physical condition, mental health condition, dementia, or cognitive difficulty that would make it impossible for you to check your own skin regularly
For people with stage IB or IIA melanoma: if a specific lymph node procedure during surgery did not successfully find the sentinel node (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lisbet R Hölmich, Professor, Herlev and Gentofte Hospital

Phone: +4538681296

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05253872

Sponsor: Herlev and Gentofte Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Melanoma

Trial contact: +4538681296

More information: https://clinicaltrials.gov/study/NCT05253872

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are able to read and understand Danish
You are willing and able to sign a consent form agreeing to take part
You have had surgery to treat an early-stage melanoma (stage IA to IIA) within the last 3 months

Who may not be able to join:

You have been diagnosed with a more advanced melanoma (stage IIB, IIC, III, or IV)
You are considered at high risk of developing a new melanoma — for example, because you have a condition called dysplastic nevus syndrome, or because melanoma runs in your family
You have had melanoma before the current diagnosis
You have had any other type of cancer in the past, not counting certain common skin cancers (non-melanoma skin cancers)
You have a physical condition, mental health condition, dementia, or cognitive difficulty that would make it impossible for you to check your own skin regularly
For people with stage IB or IIA melanoma: if a specific lymph node procedure during surgery did not successfully find the sentinel node (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Herlev and Gentofte Hospital

Registry

ClinicalTrials.gov

Start date

9 March 2022

Est. completion

1 June 2024

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Fear of cancer recurrence; Fear of cancer recurrence; Fear of cancer recurrence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov